Urinary interleukin 13 level in steroid sensitive and resistant nephrotic syndrome: a cross-sectional single center study

Abstract Nephrotic syndrome, the most common glomerular disease in pediatric population, is classified into two groups of steroid sensitive (SSNS) and resistant (SSRS). There is growing evidence on the role of T cells cytokines, including interleukin-13, in pathophysiology of nephrotic syndrome and...

Full description

Saved in:
Bibliographic Details
Main Authors: Behnam Ermian, Noosha Samieefar, Aida Vahidi, Daryoush Fahimi, Niloufar Peirovi, Mohamed Husein Aldokhi, Behnaz Bazargani, Arash Abbasi, Fahimeh Askarian, Mastaneh Moghtaderi
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-86488-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862523720368128
author Behnam Ermian
Noosha Samieefar
Aida Vahidi
Daryoush Fahimi
Niloufar Peirovi
Mohamed Husein Aldokhi
Behnaz Bazargani
Arash Abbasi
Fahimeh Askarian
Mastaneh Moghtaderi
author_facet Behnam Ermian
Noosha Samieefar
Aida Vahidi
Daryoush Fahimi
Niloufar Peirovi
Mohamed Husein Aldokhi
Behnaz Bazargani
Arash Abbasi
Fahimeh Askarian
Mastaneh Moghtaderi
author_sort Behnam Ermian
collection DOAJ
description Abstract Nephrotic syndrome, the most common glomerular disease in pediatric population, is classified into two groups of steroid sensitive (SSNS) and resistant (SSRS). There is growing evidence on the role of T cells cytokines, including interleukin-13, in pathophysiology of nephrotic syndrome and steroid response. This study was a cross-sectional study conducted at Children’s Medical Center Hospital in order to explore the relationship between urinary IL-13 levels and responsiveness to corticosteroid treatment. All children (1 to 15 years) referred from January 2021 to January 2022 diagnosed with nephrotic syndrome were included. Urine samples were collected during the initial phase or relapse of nephrotic syndrome, before the initiation of steroid or alternative treatments. Interleukin-13 levels in the urine were measured using the ELISA method. In this study, 83 cases of nephrotic syndrome were enrolled, of whom 30 (36.1%) were girls and 53 (63.9%) were boys. Out of the 83 cases, 63 (75.9%) were identified as SSNS and 20 (24.1%) as SRNS. There was no significant difference between the urinary interleukin-13 levels between SSNS and SRNS groups (P-value: 0.84). Sex (P-value: 0.598) and age (P-value: 0.704) also had no association with interleukin-13 levels. Further studies in larger population are recommended to better assess the potential of this biomarker to predict response to treatment. .
format Article
id doaj-art-d7b9e2f7b2cc49a6b901edfb0621ac64
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-d7b9e2f7b2cc49a6b901edfb0621ac642025-02-09T12:29:21ZengNature PortfolioScientific Reports2045-23222025-02-011511510.1038/s41598-025-86488-9Urinary interleukin 13 level in steroid sensitive and resistant nephrotic syndrome: a cross-sectional single center studyBehnam Ermian0Noosha Samieefar1Aida Vahidi2Daryoush Fahimi3Niloufar Peirovi4Mohamed Husein Aldokhi5Behnaz Bazargani6Arash Abbasi7Fahimeh Askarian8Mastaneh Moghtaderi9School of Medicine, Tehran University of Medical SciencesPediatric Chronic Kidney Disease Research Center, Gene, Cell & Tissue Research Institute, Children’s Medical Center, Tehran University of Medical SciencesMetabolic Disorders Research Center, Endocrinology and Metabolism Molecular- Cellular Sciences Institute, Tehran University of Medical SciencesPediatric Chronic Kidney Disease Research Center, Gene, Cell & Tissue Research Institute, Children’s Medical Center, Tehran University of Medical SciencesSchool of Medicine, Tehran University of Medical SciencesSchool of Medicine, Tehran University of Medical SciencesPediatric Chronic Kidney Disease Research Center, Gene, Cell & Tissue Research Institute, Children’s Medical Center, Tehran University of Medical SciencesPediatric Chronic Kidney Disease Research Center, Gene, Cell & Tissue Research Institute, Children’s Medical Center, Tehran University of Medical SciencesPediatric Chronic Kidney Disease Research Center, Gene, Cell & Tissue Research Institute, Children’s Medical Center, Tehran University of Medical SciencesPediatric Chronic Kidney Disease Research Center, Gene, Cell & Tissue Research Institute, Children’s Medical Center, Tehran University of Medical SciencesAbstract Nephrotic syndrome, the most common glomerular disease in pediatric population, is classified into two groups of steroid sensitive (SSNS) and resistant (SSRS). There is growing evidence on the role of T cells cytokines, including interleukin-13, in pathophysiology of nephrotic syndrome and steroid response. This study was a cross-sectional study conducted at Children’s Medical Center Hospital in order to explore the relationship between urinary IL-13 levels and responsiveness to corticosteroid treatment. All children (1 to 15 years) referred from January 2021 to January 2022 diagnosed with nephrotic syndrome were included. Urine samples were collected during the initial phase or relapse of nephrotic syndrome, before the initiation of steroid or alternative treatments. Interleukin-13 levels in the urine were measured using the ELISA method. In this study, 83 cases of nephrotic syndrome were enrolled, of whom 30 (36.1%) were girls and 53 (63.9%) were boys. Out of the 83 cases, 63 (75.9%) were identified as SSNS and 20 (24.1%) as SRNS. There was no significant difference between the urinary interleukin-13 levels between SSNS and SRNS groups (P-value: 0.84). Sex (P-value: 0.598) and age (P-value: 0.704) also had no association with interleukin-13 levels. Further studies in larger population are recommended to better assess the potential of this biomarker to predict response to treatment. .https://doi.org/10.1038/s41598-025-86488-9Nephrotic syndromeSteroidsNephrotic syndromeIdiopathicSteroid-resistantChild
spellingShingle Behnam Ermian
Noosha Samieefar
Aida Vahidi
Daryoush Fahimi
Niloufar Peirovi
Mohamed Husein Aldokhi
Behnaz Bazargani
Arash Abbasi
Fahimeh Askarian
Mastaneh Moghtaderi
Urinary interleukin 13 level in steroid sensitive and resistant nephrotic syndrome: a cross-sectional single center study
Scientific Reports
Nephrotic syndrome
Steroids
Nephrotic syndrome
Idiopathic
Steroid-resistant
Child
title Urinary interleukin 13 level in steroid sensitive and resistant nephrotic syndrome: a cross-sectional single center study
title_full Urinary interleukin 13 level in steroid sensitive and resistant nephrotic syndrome: a cross-sectional single center study
title_fullStr Urinary interleukin 13 level in steroid sensitive and resistant nephrotic syndrome: a cross-sectional single center study
title_full_unstemmed Urinary interleukin 13 level in steroid sensitive and resistant nephrotic syndrome: a cross-sectional single center study
title_short Urinary interleukin 13 level in steroid sensitive and resistant nephrotic syndrome: a cross-sectional single center study
title_sort urinary interleukin 13 level in steroid sensitive and resistant nephrotic syndrome a cross sectional single center study
topic Nephrotic syndrome
Steroids
Nephrotic syndrome
Idiopathic
Steroid-resistant
Child
url https://doi.org/10.1038/s41598-025-86488-9
work_keys_str_mv AT behnamermian urinaryinterleukin13levelinsteroidsensitiveandresistantnephroticsyndromeacrosssectionalsinglecenterstudy
AT nooshasamieefar urinaryinterleukin13levelinsteroidsensitiveandresistantnephroticsyndromeacrosssectionalsinglecenterstudy
AT aidavahidi urinaryinterleukin13levelinsteroidsensitiveandresistantnephroticsyndromeacrosssectionalsinglecenterstudy
AT daryoushfahimi urinaryinterleukin13levelinsteroidsensitiveandresistantnephroticsyndromeacrosssectionalsinglecenterstudy
AT niloufarpeirovi urinaryinterleukin13levelinsteroidsensitiveandresistantnephroticsyndromeacrosssectionalsinglecenterstudy
AT mohamedhuseinaldokhi urinaryinterleukin13levelinsteroidsensitiveandresistantnephroticsyndromeacrosssectionalsinglecenterstudy
AT behnazbazargani urinaryinterleukin13levelinsteroidsensitiveandresistantnephroticsyndromeacrosssectionalsinglecenterstudy
AT arashabbasi urinaryinterleukin13levelinsteroidsensitiveandresistantnephroticsyndromeacrosssectionalsinglecenterstudy
AT fahimehaskarian urinaryinterleukin13levelinsteroidsensitiveandresistantnephroticsyndromeacrosssectionalsinglecenterstudy
AT mastanehmoghtaderi urinaryinterleukin13levelinsteroidsensitiveandresistantnephroticsyndromeacrosssectionalsinglecenterstudy